A placebo-controlled, parallel group study of HTU-520 in patients with onychomycosis.

Trial Profile

A placebo-controlled, parallel group study of HTU-520 in patients with onychomycosis.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 May 2016

At a glance

  • Drugs Terbinafine (Primary)
  • Indications Onychomycosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Hisamitsu Pharmaceutical
  • Most Recent Events

    • 25 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top